カテゴリ： QYResearch, 世界, 医療/バイオ

サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の世界市場2023年：25ml、50ml、100ml

■ 英語タイトル：Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8733）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8733
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の世界市場2023年：25ml、50ml、100ml]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）のグローバル市場について調査・分析し、世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（25ml、50ml、100ml）、用途別セグメント分析（ホスピス、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、CSL、Biotest、Beijing Tiantan Biological Products、Taibang Biologic Group、Shanxi Kangbao Biological Productなどが含まれています。サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模を算出する際に考慮しました。

・サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場の概要
- 製品の定義
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の種類別セグメント
- 世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模：タイプ別分析（25ml、50ml、100ml）
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の用途別セグメント
- 世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模：用途別分析（ホスピス、クリニック、その他）
- 世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模予測（2018年-2029年）
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場の競争状況およびトレンド

・サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の地域別市場規模
- 北米のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- 米国のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- ヨーロッパのサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- アジア太平洋のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- 中国のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- 日本のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- 韓国のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- インドのサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- オーストラリアのサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- 中南米のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）
- 中東・アフリカのサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場規模（2018年-2029年）

・種類別セグメント：25ml、50ml、100ml
- 世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）のタイプ別販売量（2018年-2023年）
- 世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）のタイプ別売上（2018年-2023年）
- 世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）のタイプ別価格

・用途別セグメント：ホスピス、クリニック、その他
- 世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の用途別販売量（2018年-2023年）
- 世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の用途別売上（2018年-2023年）
- 世界のサイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
CSL、Biotest、Beijing Tiantan Biological Products、Taibang Biologic Group、Shanxi Kangbao Biological Product

・産業チェーンと販売チャネルの分析
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）産業チェーン分析
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の主要原材料
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の販売チャネル
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）のディストリビューター
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の主要顧客

・サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場ダイナミクス
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の業界動向
- サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Intravenous cytomegalovirus immunoglobulin (human) is used to prevent cytomegalovirus disease associated with kidney, lung, liver, pancreas, and heart transplantation. Prophylactic CMV-IGIV should be used in combination with ganciclovir in transplants of these organs other than the kidneys of CMV seropositive donors into seronegative recipients.
Highlights
The global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) include CSL, Biotest, Beijing Tiantan Biological Products, Taibang Biologic Group and Shanxi Kangbao Biological Product, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV).
The Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
CSL
Biotest
Beijing Tiantan Biological Products
Taibang Biologic Group
Shanxi Kangbao Biological Product
Segment by Type
25 ml
50 ml
100 ml
Segment by Application
Hopistial
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Overview
1.1 Product Overview and Scope of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)
1.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Segment by Type
1.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Value Comparison by Type (2023-2029)
1.2.2 25 ml
1.2.3 50 ml
1.2.4 100 ml
1.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Segment by Application
1.3.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Value by Application: (2023-2029)
1.3.2 Hopistial
1.3.3 Clinic
1.3.4 Others
1.4 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size Estimates and Forecasts
1.4.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue 2018-2029
1.4.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales 2018-2029
1.4.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Competition by Manufacturers
2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price by Manufacturers (2018-2023)
2.4 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), Product Type & Application
2.7 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Competitive Situation and Trends
2.7.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Players Market Share by Revenue
2.7.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Retrospective Market Scenario by Region
3.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region: 2018-2029
3.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region: 2018-2023
3.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region: 2024-2029
3.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region: 2018-2029
3.3.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region: 2018-2023
3.3.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region: 2024-2029
3.4 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Country
3.4.1 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2018-2029)
3.4.3 North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Country
3.5.1 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2018-2029)
3.5.3 Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Country
3.6.1 Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2018-2029)
3.6.3 Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Country
3.7.1 Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2018-2029)
3.7.3 Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Facts & Figures by Country
3.8.1 Middle East and Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2018-2029)
4.1.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2018-2023)
4.1.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Type (2024-2029)
4.1.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Type (2018-2029)
4.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2018-2029)
4.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2018-2023)
4.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Type (2024-2029)
4.2.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Type (2018-2029)
4.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2018-2029)
5.1.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2018-2023)
5.1.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Application (2024-2029)
5.1.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Application (2018-2029)
5.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2018-2029)
5.2.1 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2018-2023)
5.2.2 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Application (2024-2029)
5.2.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Application (2018-2029)
5.3 Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Biotest
6.2.1 Biotest Corporation Information
6.2.2 Biotest Description and Business Overview
6.2.3 Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
6.2.5 Biotest Recent Developments/Updates
6.3 Beijing Tiantan Biological Products
6.3.1 Beijing Tiantan Biological Products Corporation Information
6.3.2 Beijing Tiantan Biological Products Description and Business Overview
6.3.3 Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
6.3.5 Beijing Tiantan Biological Products Recent Developments/Updates
6.4 Taibang Biologic Group
6.4.1 Taibang Biologic Group Corporation Information
6.4.2 Taibang Biologic Group Description and Business Overview
6.4.3 Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
6.4.5 Taibang Biologic Group Recent Developments/Updates
6.5 Shanxi Kangbao Biological Product
6.5.1 Shanxi Kangbao Biological Product Corporation Information
6.5.2 Shanxi Kangbao Biological Product Description and Business Overview
6.5.3 Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product Portfolio
6.5.5 Shanxi Kangbao Biological Product Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Chain Analysis
7.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Production Mode & Process
7.4 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales and Marketing
7.4.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Channels
7.4.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Distributors
7.5 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Customers
8 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Dynamics
8.1 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Industry Trends
8.2 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Drivers
8.3 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Challenges
8.4 Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price (US$/Units) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), Product Type & Application
Table 12. Global Key Manufacturers of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region (2018-2023) & (K Units)
Table 18. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Region (2018-2023)
Table 19. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region (2024-2029) & (K Units)
Table 20. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Region (2024-2029)
Table 21. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Region (2018-2023)
Table 23. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Region (2024-2029)
Table 25. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2018-2023) & (K Units)
Table 27. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2024-2029) & (K Units)
Table 28. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2018-2023) & (K Units)
Table 32. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2024-2029) & (K Units)
Table 33. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units) by Type (2018-2023)
Table 51. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units) by Type (2024-2029)
Table 52. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Type (2018-2023)
Table 53. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Type (2024-2029)
Table 54. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Type (2018-2023)
Table 57. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Type (2024-2029)
Table 58. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price (US$/Units) by Type (2018-2023)
Table 59. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price (US$/Units) by Type (2024-2029)
Table 60. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units) by Application (2018-2023)
Table 61. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units) by Application (2024-2029)
Table 62. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Application (2018-2023)
Table 63. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Application (2024-2029)
Table 64. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Application (2018-2023)
Table 67. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Application (2024-2029)
Table 68. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price (US$/Units) by Application (2018-2023)
Table 69. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price (US$/Units) by Application (2024-2029)
Table 70. CSL Corporation Information
Table 71. CSL Description and Business Overview
Table 72. CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2018-2023)
Table 73. CSL Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product
Table 74. CSL Recent Developments/Updates
Table 75. Biotest Corporation Information
Table 76. Biotest Description and Business Overview
Table 77. Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2018-2023)
Table 78. Biotest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product
Table 79. Biotest Recent Developments/Updates
Table 80. Beijing Tiantan Biological Products Corporation Information
Table 81. Beijing Tiantan Biological Products Description and Business Overview
Table 82. Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2018-2023)
Table 83. Beijing Tiantan Biological Products Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product
Table 84. Beijing Tiantan Biological Products Recent Developments/Updates
Table 85. Taibang Biologic Group Corporation Information
Table 86. Taibang Biologic Group Description and Business Overview
Table 87. Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2018-2023)
Table 88. Taibang Biologic Group Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product
Table 89. Taibang Biologic Group Recent Developments/Updates
Table 90. Shanxi Kangbao Biological Product Corporation Information
Table 91. Shanxi Kangbao Biological Product Description and Business Overview
Table 92. Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (K Units), Revenue (US$ Million), Price (US$/Units) and Gross Margin (2018-2023)
Table 93. Shanxi Kangbao Biological Product Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Product
Table 94. Shanxi Kangbao Biological Product Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Distributors List
Table 98. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Customers List
Table 99. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Trends
Table 100. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Drivers
Table 101. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Challenges
Table 102. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV)
Figure 2. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Share by Type in 2022 & 2029
Figure 4. 25 ml Product Picture
Figure 5. 50 ml Product Picture
Figure 6. 100 ml Product Picture
Figure 7. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Share by Application in 2022 & 2029
Figure 9. Hopistial
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size (2018-2029) & (US$ Million)
Figure 14. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales (2018-2029) & (K Units)
Figure 15. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Average Price (US$/Units) & (2018-2029)
Figure 16. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Report Years Considered
Figure 17. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Share by Manufacturers in 2022
Figure 18. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Players: Market Share by Revenue in 2022
Figure 20. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Country (2018-2029)
Figure 23. North America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Country (2018-2029)
Figure 27. Europe Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Country (2018-2029)
Figure 28. Germany Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Region (2018-2029)
Figure 35. China Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Country (2018-2029)
Figure 46. Latin America Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) by Type (2018-2029)
Figure 56. Global Revenue Market Share of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) by Type (2018-2029)
Figure 57. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price (US$/Units) by Type (2018-2029)
Figure 58. Global Sales Market Share of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) by Application (2018-2029)
Figure 59. Global Revenue Market Share of Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) by Application (2018-2029)
Figure 60. Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Price (US$/Units) by Application (2018-2029)
Figure 61. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Value Chain
Figure 62. Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • イオキサノール用調製の世界市場2023-2029：50ml：16g、100ml：27g、100ml：32g
  • グルコースIVバッグのグローバル市場2023：50ml、100ml、500ml、その他
  • 塩化ナトリウムIVバッグのグローバル市場2023：50ml、100ml、500ml、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8733 )"サイトメガロウイルス抗体ヒト免疫グロブリン（CMV-IGIV）の世界市場2023年：25ml、50ml、100ml" (英文：Global Cytomegalovirus Immune Globulin Intravenous Human (CMV-IGIV) Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。